Medicare Enrolled
Dr. Daniel Cho, M.D.
Gastroenterology · Torrance, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cho from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cho?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cho
Dr. Daniel Cho is a gastroenterology specialist in Torrance, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Cho performed 1,185 Medicare services across 872 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cho received a total of $6,094 from 36 pharmaceutical and/or device companies across 288 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cho is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 27% volume in CA
$6,094 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,185
Medicare services
Top 27% in CA for gastroenterology
872
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~66 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
222 | $67 | $130 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
220 | $31 | $249 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
152 | $80 | $190 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
97 | $41 | $65 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
92 | $78 | $950 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
81 | $93 | $230 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
68 | $122 | $1,075 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
47 | $219 | $1,300 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
32 | $109 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $102 | $190 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
28 | $192 | $1,025 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
26 | $153 | $1,025 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
25 | $66 | $110 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
25 | $188 | $1,000 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
21 | $56 | $130 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
18 | $69 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,094
Total received (2018-2024)
Avg $871/year across 7 years
Top 26% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
288
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,807 (95.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$287 (4.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,187
2023
$633
2022
$1,552
2021
$1,545
2020
$652
2019
$291
2018
$234
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$207
Boston Scientific Corporation
$196
Gilead Sciences, Inc.
$157
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$90
Merck Sharp & Dohme LLC
$80
Janssen Scientific Affairs, LLC
$73
Takeda Pharmaceuticals U.S.A., Inc.
$59
Madrigal Pharmaceuticals
$55
PFIZER INC.
$46
Ipsen Biopharmaceuticals, Inc
$40
Janssen Biotech, Inc.
$39
GENZYME CORPORATION
$27
Celltrion USA Inc.
$25
IRONWOOD PHARMACEUTICALS, INC
$24
Organon Llc
$19
Intercept Pharmaceuticals, Inc.
$18
Ardelyx, Inc.
$17
Celgene Corporation
$16
Top 3 companies account for 47.1% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$1,054
ABBVIE INC.
$864
Gilead Sciences, Inc.
$666
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$512
Boston Scientific Corporation
$316
Janssen Biotech, Inc.
$280
Celgene Corporation
$273
Merck Sharp & Dohme LLC
$260
Takeda Pharmaceuticals U.S.A., Inc.
$231
Shire North American Group Inc
$200
PFIZER INC.
$152
IRONWOOD PHARMACEUTICALS, INC
$135
Merck Sharp & Dohme Corporation
$135
Alfasigma USA, Inc.
$117
Ironwood Pharmaceuticals, Inc
$85
Organon LLC
$77
Janssen Scientific Affairs, LLC
$73
Nestle HealthCare Nutrition Inc.
$73
GENZYME CORPORATION
$62
Amgen Inc.
$61
Madrigal Pharmaceuticals
$55
Intercept Pharmaceuticals, Inc.
$55
Celltrion USA Inc.
$47
RedHill Biopharma Inc.
$41
Ipsen Biopharmaceuticals, Inc
$40
AIMMUNE THERAPEUTICS, INC.
$33
INTERCEPT PHARMACEUTICALS, INC.
$30
AbbVie, Inc.
$29
Ethicon US, LLC
$28
Romark Laboratories, LC
$22
Organon Llc
$19
Ardelyx, Inc.
$17
QOL Medical, LLC
$16
W. L. Gore & Associates, Inc.
$13
Allergan Inc.
$11
Shionogi Inc
$11
Top 3 companies account for 42.4% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Alinia Tablets 500mg 30 count bottle · CARDIOFORM Septal Occluder · CREON · Creon · DIFICID · DUPIXENT · ENTYVIO · EXALT Model D · HADLIMA · HUMIRA · IBSRELA · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · Movantik · Mulpleta · NEXPLANON · OCALIVA · ORCAPOD · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · TREMFYA · TRULANCE · Talicia · VIBERZI · VOWST · Vemlidy · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
400
Per 100K population
4.1
County median income
$87,760
Nearest hospital
DEL AMO HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cho is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cho experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Cho performed 222 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cho receive payments from pharmaceutical companies?
Yes. Dr. Cho received a total of $6,094 from 36 companies across 288 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cho's costs compare to other gastroenterologists in Torrance?
Dr. Cho's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cho) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Torrance
Browse gastroenterologists in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology